Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-03-22
2005-03-22
Achutamurthy, Ponnathapura (Department: 1652)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C435S069200, C530S350000
Reexamination Certificate
active
06869925
ABSTRACT:
Methods and pharmaceutical compositions are provided to prevent retroviral infections of host cells. More particularly, the invention relates to prevention of HIV infection of human cells by serine leukocyte protease inhibitor (SLPI).
REFERENCES:
patent: 4394443 (1983-07-01), Weissman et al.
patent: 4511503 (1985-04-01), Olson et al.
patent: 4530901 (1985-07-01), Weissman
patent: 4546082 (1985-10-01), Kurjan et al.
patent: 4595674 (1986-06-01), Tschesche et al.
patent: 4626510 (1986-12-01), Grandi
patent: 4652639 (1987-03-01), Stabinsky
patent: 4672032 (1987-06-01), Slavkin et al.
patent: 4711848 (1987-12-01), Insley et al.
patent: 4720454 (1988-01-01), White et al.
patent: 4760130 (1988-07-01), Thompson et al.
patent: 4788135 (1988-11-01), Davis et al.
patent: 4829052 (1989-05-01), Glover et al.
patent: 4845076 (1989-07-01), Heinzel et al.
patent: 4891356 (1990-01-01), Szabo
patent: 4916117 (1990-04-01), Lezdey et al.
patent: 4923807 (1990-05-01), Webb et al.
patent: 4952512 (1990-08-01), Loskutoff et al.
patent: 5102995 (1992-04-01), Tollefesen et al.
patent: 5109113 (1992-04-01), Caras et al.
patent: 5134119 (1992-07-01), Lezdey et al.
patent: 5151438 (1992-09-01), Sham et al.
patent: 5151509 (1992-09-01), Kotwal et al.
patent: 5157019 (1992-10-01), Glover et al.
patent: 5196404 (1993-03-01), Maraganore et al.
patent: 5215915 (1993-06-01), Tiberi et al.
patent: 5252725 (1993-10-01), Rubin et al.
patent: 5290762 (1994-03-01), Lezdey et al.
patent: 5376633 (1994-12-01), Lezdey et al.
patent: 5514662 (1996-05-01), Seman et al.
patent: 5532215 (1996-07-01), Lezdey et al.
patent: 6017880 (2000-01-01), Eisenberg et al.
patent: 6132990 (2000-10-01), Bandyopadhyay et al.
patent: 0114506 (1984-08-01), None
patent: 0 346 500 (1994-07-01), None
patent: WO 8403711 (1984-09-01), None
patent: WO 8603497 (1986-06-01), None
patent: WO 8603519 (1986-06-01), None
patent: WO 9309791 (1993-05-01), None
Kueppers, F., Biochimica et Biophysica Acta, vol. 299, “Proteinase inhibitor in human tears”, pp. 845-849, 1971.*
Wallner, O., et al., Hoppe-Seyler's Z. Physiol. Chem., vol. 355, “Characterization of an acid-stable proteinase inhibitor in human cervical mucus”, pp. 709-715, 1974.*
Burnon, D. E., et al., “Activity of some peptide hydrolase enzymes in fresh and stored poultry semen from full sib groups of males and their relation to fertility”, Chemical Abstracts, vol. 84, No. 28236, 1975.*
Schiessler, H., et al., Hoppe-Seyler's Z. Physiol. Chem., vol. 357, “Inhibitors of acrosin and granulocyte proteinases from human genital tract secretions”, pp. 1251-1260, 1976.*
Ohlsson, K., et al., Hoppe-Seyler's Z. Physiol. Chem., vol. 358, “Isolation and partial characterization of a low molecular weight acid stable protease inhibitor from human bronchial secretion”, pp. 583-589, 1977.*
Scheissler, H., et al., in Neutral Proteases of Human Polymorphonuclear Leukocytes, Havemann, K., et al., Eds., “Acid stable inhibitors of granulocyte neutral proteases in human mucous secretions . . . ”, Chemical Abstracts, vol. 89, No. 192866u, 1978.*
Fritz, H., et al., Agents and Actions, vol. 8, “Naturally-occurring low molecular weight inhibitors of neutral proteinases from PMN-granulocytes and of kallikreins”, pp. 57-64, 1978.*
Scheissler, H., et al., in Human Fertilization, Ludwig, H., et al., Eds., “Inhibitors of granulocyte proteases (antileukoprotease) in human genital tract secretions,” pp. 101-106, 1978.*
Lovett, P. S., et al., Methods in Enzymology, vol. 68, “Bacillus subtilisas a host for molecular cloning”, pp. 342-357, 1979.*
Schleisser, H., et al., “Inhibitors of granulocyte protease (antileukoprotease) in human genital tract secretions”, Chemical Abstracts, vol. 90, No. 117084e, 1979.*
Movva, N. R., et al., Journal of Molecular Biology, vol. 143, “Gene structure of the OmpA protein, a major cell surface protein ofEscherichia colirequired for cell-cell interaction”, pp. 317-328, 1980.*
Fritz, H., in Protein Degradation in Health and Disease, Ciba Foundation Symposium, “Proteinase inhibitors in severe inflammatory processes (septic shock and experimental endotoxaemia): biochemical, pathophysiological and therapeutic aspects”, pp. 351-, 1980.*
Svendsen, I., et al., “Amino acid sequence homology between a serine protease inhibitor from barley and potato inhibitor I”, Chemical Abstracts, vol. 95, No. 2484w, 1981.*
Chandrasekar, M., et al., “Synthesis of a fragment of the active center of serine proteases”, Chemical Abstracts, vol. 95, No. 169751, 1981.*
Miller, W. L., et al., Drug Development Research, vol. 1, “Synthesis of biologically active proteins by recombinant DNA technology”, pp. 435-454, 1981.*
Hewick, R. M., et al., Journal of Biological Chemistry, vol. 256, “A gas-liquid solid phase peptide and protein sequenator”, pp. 7990-7997, 1981.*
Kurachi, K., et al., Proceedings of the National Academy of Sciences, U.S.A., vol. 78, “Cloning and sequence of cDNA coding for alpha1-antitrypsin”, pp. 6826-6830, 1981.*
Svendsen, I., et al., “Amino acid sequence of serine protease inhibitor Cl-1 from barley: Homology with barley inhibtor Ci-2, potato inhibitor I and leech eglin”, Chemical Abstracts, vol. 97, No. 51668j, 1982.*
Leicht, M., et al., Nature, vol. 297, “Sequence homology and structural comparison between the chromosomal human alpha1-antitrypsin and chicken ovalbumin genes”, pp. 655-659, 1982.*
Valenzuela, P., et al., Nature, vol. 298, “Synthesis and assembly of hepatitis B virus surface antigen particles in yeast”, pp. 347-350, 1982.*
Kurjan, J., et al., Cell, vol. 30, “Structure of a yeast pheromone gene (MFalpha): A putative alpha-factor precursor contains four tandem copies of mature alpha-factor”, pp. 933-934, 1982.*
Swift, G. H., et al., Proceedings of the National Academy of Sciences, U.S.A., vol. 79, “Rat pancreatic kallikrein mRNA: Nucleotide sequence and amino acid sequence of the encoded preproenzyme”, pp. 7623-7627, 1982.*
Maniatis, T., et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Procedures for cDNA cloning (excerpt), p. 231, 1982.*
Maniatis, T., et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, “Extraction, purification, and analysis of mRNA from eukaryotic cells (excerpt)”, pp. 190-193, 1982.*
Botstein, D., et al., in The Molecular Biology of the YeastSaccharomyces, Strathern, J. N., et al., Eds., Cold Spring Harbor Laboratory, “Principles and practice of recombinant DNA research with yeast”, pp. 607-636, 1982.*
Helfman, D. M., et al., Proceedings of the National Academy of Sciences, U.S.A., vol. 80, “Identification of clones that encode chicken tropomyosin by direct immunological screening of a cDNA expression library”, pp. 31-35, 1983.*
Young, R.A., et al., Proceedings of the National Academy of Sciences, U.S.A., vol. 80, “Efficient isolation of genes by using antibody probes”, pp. 1194-1198, 1983.*
Amann, E., et al., Gene, vol. 25, “Vectors bearing a hybrid trp-lac promoter useful for regulated expression of cloned genes inEscherichia coli”, pp. 167-178, 1983.*
Ohlsson, M., et al., Hoppe-Zeyler's Z. Physiol. Chem., vol. 364, “Quantification of granulocyte elastase inhibitors in human mixed saliva and in pure parotid secretion”, pp. 1323-1328, 1983.*
Rogers, J., et al., Biochemical and Biophysical Research Communications, vol. 116, “The isolation of a clone for human alpha1-antitrypsin and the detection of alpha1-antitrypsin in mRNA from liver and leukocytes”, pp. 375-382, 1983.*
Anderson, s., et al., Proceedings of the National Academy of Sciences, U.S.A.,vol. 80, “Isolation of a genomic clone for bovine pancreatic trypsin inhibitor by using a unique-sequence synthetic DNA probe”, pp. 6838-6842, 1983.*
Eisenberg Stephen
Thompson Robert C.
Wahl Sharon M.
Achutamurthy Ponnathapura
Amgen Inc.
Moore William W.
The United States of America as represented by the Department of
LandOfFree
Inhibition of retrovirus infection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of retrovirus infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of retrovirus infection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3422202